Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients (DECREASE)
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to determine efficacy of a dedicated programming concept for avoidance of inappropriate implantable cardioverter defibrillator (ICD) therapies in patient with primary prevention ICD indication.
Full description
Inappropriate ICD therapies still remains a major issue with respect to patient's quality of life and proarrhythmic risk.
It's the aim of this study to determine efficacy of a dedicated programming concept for avoidance of inappropriate ICD therapy in patients who received the ICD for primary prevention of sudden cardiac death.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Approved indication for new ICD implantation for primary prevention of sudden cardiac death
- Age >=18 Years
- Written informed consent
Exclusion criteria
- ICD indication for secondary prevention reasons
- ICD indication for "electrical" disorders (i.e. long/short QT syndrome, Brugada syndrome etc...)
- ICD change or upgrade
- Pregnancy
- Nonage
- Patient is already participating to another study with active therapy arm
- Patient will most likely not be able to participate to the routine follow ups in the study center.
Trial design
Primary purpose
Allocation
Interventional model
Masking
543 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal